1887
Volume 2025, Issue 4
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Schimke immunoosseous dysplasia (SIOD) is a condition marked by spondyloepiphyseal dysplasia (SED), leading to short stature, nephropathy, and T-cell immunodeficiency.

A 15-year-old male was referred to the nephrology clinic with a gradual onset of lower-limb swelling. Clinical examination revealed short stature. Laboratory studies revealed renal impairment and nephrotic-range proteinuria. Kidney biopsy showed global sclerosis in 3 of 28 glomeruli, segmental sclerosis in 16 of 28 glomeruli, and 90% foot-process effacement on electron microscopy. A skeletal survey showed flattened thoracolumbar vertebral bodies, a characteristic feature of SIOD. Flow cytometry revealed a low CD4 count. Whole-exome sequencing confirmed that the proband was homozygous for the p.(R611C) variant in the gene. The patient was treated with a calcineurin inhibitor (CNI), angiotensin receptor blockers (ARBs), and prophylactic anticoagulation. Initially, he experienced improvement in serum albumin levels and proteinuria. However, his urine protein and creatinine levels subsequently increased, prompting discontinuation of CNI. The patient progressed to end-stage kidney disease (ESKD) and required hemodialysis 18 months after the initial presentation.

This report describes a case of SIOD, a rare multisystem disorder characterized by short stature due to SED and nephrotic syndrome, distinguishing it from other hereditary nephrotic syndromes. The patient presented unusually in adolescence with nephrotic-range proteinuria and skeletal abnormalities, representing a rarely reported juvenile variant. Genetic testing revealed a novel homozygous mutation, p.(R611C), which was confirmed in his younger sibling. However, the phenotypic expression differed, reflecting the weak genotype–phenotype correlation in SIOD. Unlike many SIOD cases, our patient did not experience recurrent infections despite abnormal immune parameters, suggesting a milder immunodeficiency and making kidney transplantation with cautious immunosuppression a feasible option. Current therapeutic challenges include the lack of effective disease-specific treatments, limited success with conventional transplantation due to infection and malignancy risks, and emerging but logistically complex approaches such as combined stem-cell and kidney transplantation.

SIOD is a rare genetic disorder with variable presentation and outcomes. Our patient, carrying a novel mutation and presenting with juvenile-onset disease, progressed to ESKD but had only mild immune dysfunction, making kidney transplantation a potential treatment option. Early recognition is essential to avoid unnecessary treatments, guide supportive care, and enable timely referral for advanced therapies. Clinicians should consider SIOD in patients presenting with short stature and nephrotic syndrome to optimize outcomes.

© 2025 Elshirbeny, Nauman, Abuhelaiga, Almalki, licensee HBKU Press.
Loading

Article metrics loading...

/content/journals/10.5339/qmj.2025.121
2025-12-15
2025-12-16

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/qmj/2025/4/qmj.2025.121.html?itemId=/content/journals/10.5339/qmj.2025.121&mimeType=html&fmt=ahah

References

  1. Boerkoel CF, Takashima H, John J, Yan J, Stankiewicz P, Rosenbarker L, et al.. Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia. Nat Genet. 2002 Feb; 30:(2):215–20. https://doi.org/10.1038/ng821
     [Google Scholar]
  2. Milovanova A, Ananin P, Vashurina T, Zrobok O, Dmitrienko S, Ryaposova A, et al.. Genetic and clinical features of Schimke immuno-osseous dysplasia: Single-centre retrospective study of 21 unrelated paediatric patients over a period of 20 years. Int J Mol Sci. 2025 Feb 18; 26:(4):1744. https://doi.org/10.3390/ijms26041744
     [Google Scholar]
  3. Jin J, Wu K, Liu Z, Chen X, Jiang S, Wang Z, et al.. Whole exome sequencing identified a novel biallelic SMARCAL1 Mutation in the extremely rare disease SIOD. Front Genet. 2019 Jun 18; 10:: 565. https://doi.org/10.3389/fgene.2019.00565
     [Google Scholar]
  4. Elizondo LI, Cho KS, Zhang W, Yan J, Huang C, Huang Y, et al.. Schimke immuno-osseous dysplasia: SMARCAL1 loss-of-function and phenotypic correlation. J Med Genet. 2009 Jan; 46:(1):49–59. https://doi.org/10.1136/jmg.2008.060095. Epub 2008 Sep 19. [PubMed].
    [Google Scholar]
  5. Finsen SH, Tepel M, Neland M, Rittig S, Thiesson HC. Successful low-dose immunotherapy after kidney transplantation in a 10-year-old girl with Schimke immuno-osseous dysplasia. Pediatr Transplant. 2023 Aug; 27:(5):e14495. https://doi.org/10.1111/petr.14495
     [Google Scholar]
  6. Bertaina A, Grimm PC, Weinberg K, Parkman R, Kristovich KM, Barbarito G, et al.. Sequential stem cell-kidney transplantation in Schimke immuno-osseous dysplasia. N Engl J Med. 2022 Jun 16; 386:(24):2295–302. https://doi.org/10.1056/NEJMoa2117028
     [Google Scholar]
  7. Ben-Omran T, Al Ghanim K, Yavarna T, El Akoum M, Samara M, Chandra P, et al.. Effects of consanguinity in a cohort of subjects with certain genetic disorders in Qatar. Mol Genet Genomic Med. 2020 Jan; 8:(1):e1051. https://doi.org/10.1002/mgg3.1051
     [Google Scholar]
  8. Kidney Disease: Improving Global Outcomes (KDIGO) Nephrotic Syndrome in Children Work Group. KDIGO 2025 clinical practice guideline for the management of nephrotic syndrome in children. Kidney Int. 2025; 107:(5 Suppl 5):S241–89. https://doi.org/10.1016/j.kint.2024.11.007
     [Google Scholar]
  9. Sarin S, Javidan A, Boivin F, Alexopoulou I, Lukic D, Svajger B, et al.. Insights into the renal pathogenesis in Schimke immuno-osseous dysplasia: A renal histological characterization and expression analysis. J Histochem Cytochem. 2015 Jan; 63:(1):32–44. https://doi.org/10.1369/0022155414558335
     [Google Scholar]
  10. Zieg J, Bezdíka M, Nmíková M, Balašáková M. Schimke immunoosseous dysplasia: An ultra-rare disease. a 20-year case series from the tertiary hospital in the Czech Republic. Ital J Pediatr. 2023 Jan 19; 49:(1):11. https://doi.org/10.1186/s13052-023-01413-y
     [Google Scholar]
  11. Diwakar G, Deepthi P, RajaKarthik K, Sriram S, Swarnalatha G, Gangadhar T. Galloway-Mowat syndrome - Unusual form of nephrotic syndrome in adolescent. Saudi J Kidney Dis Transpl. 2017 Sep–Oct; 28:(5):1188–91. https://doi.org/10.4103/1319-2442.215154
     [Google Scholar]
  12. Quinzii CM, DiMauro S, Hirano M. Human coenzyme Q10 deficiency. Neurochem Res. 2007;32:: 723–27. https://doi.org/10.1007/s11064-006-9190-z
     [Google Scholar]
  13. Yoshimi A, Ishikawa K, Niemeyer C, Grünert SC. Pearson syndrome: A multisystem mitochondrial disease with bone marrow failure. Orphanet J Rare Dis. 2022; 17:: 379. https://doi.org/10.1186/s13023-022-02538-9
     [Google Scholar]
  14. Lücke T, Franke D, Clewing JM, Boerkoel CF, Ehrich JH, Das AM, et al.. Schimke versus non-Schimke chronic kidney disease: An anthropometric approach. Pediatrics. 2006 Aug; 118:(2):e400–7. https://doi.org/10.1542/peds.2005-2614
     [Google Scholar]
  15. Lipska-Zitkięwicz BS, Gellermann J, Boyer O, Gribouval O, Zitkięwicz S, Kari JA, et al.. Low renal but high extrarenal phenotype variability in Schimke immuno-osseous dysplasia. PLoS One. 2017 Aug 10; 12:(8):e0180926. https://doi.org/10.1371/journal.pone.0180926
     [Google Scholar]
  16. Boerkoel CF, O’Neill S, André JL, Benke PJ, Bogdanoví R, Bulla M, et al.. Manifestations and treatment of Schimke immuno-osseous dysplasia: 14 new cases and a review of the literature. Eur J Pediatr. 2000 Jan-Feb; 159:(1-2):1–7. https://doi.org/10.1007/s004310050001
     [Google Scholar]
  17. Hashimoto K, Takeuchi A, Ieshima A, Takada M, Kasagi M. Juvenile variant of Schimke immunoosseous dysplasia. Am J Med Genet. 1994 Feb 1; 49:(3):266–9. https://doi.org/10.1002/ajmg.1320490304
     [Google Scholar]
  18. Bakr A, Eid R, Sarhan A, Hammad A, El-Refaey AM, El-Mougy A, et al.. Schimke immune-osseous dysplasia: A case report. Saudi J Kidney Dis Transpl. 2015 Sep; 26:(5):987–91. https://doi.org/10.4103/1319-2442.164585
     [Google Scholar]
  19. Lücke T, Marwedel KM, Kanzelmeyer NK, Hori A, Offner G, Kreipe HH, et al.. Generalized atherosclerosis sparing the transplanted kidney in Schimke disease. Pediatr Nephrol. 2004 Jun; 19:(6): 672–5. https://doi.org/10.1007/s00467-004-1426-z
     [Google Scholar]
  20. Cicca A, Bredemeyer AL, Sowa ME, Terret M-E, Jallepalli PV, Harper JW, et al.. The SIOD disorder protein SMARCAL1 is an RPA-interacting protein involved in replication fork restart. Genes Dev. 2009; 23:(20):2415–25. https://doi.org/10.1101/gad.1832309. [PubMed] PMC2764500.
    [Google Scholar]
  21. Lippner E, Lücke T, Salgado C, Boerkoel C, Lewis DB, Adam MP, et al.. Schimke immunoosseous dysplasia. 2002 Oct 1 [updated 2022 Apr 14]. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, et al.., (editors). GeneReviews®. Seattle:University of Washington;1993–2025.
    [Google Scholar]
  22. Lama G, Marrone N, Majorana M, Cirillo F, Salsano ME, Rinaldi MM. Spondyloepiphyseal dysplasia tarda and nephrotic syndrome in three siblings. Pediatr Nephrol. 1995 Feb; 9:(1):19–23. https://doi.org/10.1007/BF00858959
     [Google Scholar]
  23. Castellano-Martinez A, Acuñas-Soto S, Varga-Martinez R, Rodriguez-Gonzalez M, Mora-Lopez F, Iriarte-Gahete M, et al.. Different phenotypes of Schimke immuno-osseous dysplasia (SIOD) in two sisters with the same mutation in the SMARCAL1 gene. Endocr Metab Immune Disord Drug Targets. 2022; 22:(8):888–94. https://doi.org/10.2174/1871530322666220223154028
     [Google Scholar]
  24. Woo HA, Kim SH, Ahn YH, Min SI, Ha J, Ha I-S, et al.. Clinical course of post-kidney transplant Schimke immuno-osseous dysplasia. Pediatr Transplant. 2023 Dec; 27:(8):e14605. https://doi.org/10.1111/petr.14605
     [Google Scholar]
/content/journals/10.5339/qmj.2025.121
Loading
Schimke immunoosseous dysplasia (SIOD): Delayed onset of rare disease and novel variant
Qatar Medical Journal 2025, 121 (2025); https://doi.org/10.5339/qmj.2025.121
/content/journals/10.5339/qmj.2025.121
/content/journals/10.5339/qmj.2025.121
Loading

Data & Media loading...

  • Article Type: Case Report
Keyword(s): end-stage kidney disease, proteinuria, Qatar and Schimke immunoosseous dysplasia

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error